Vertex Pharmaceuticals Incorporated

VRTX·NasdaqGS·Healthcare
Compare
549.04+18.28 (+3.44%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market546.68−2.36 (−0.43%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close530.76
Open535.63
Day range527.38550.77
52-week range406.67568.67
Off day high−0.31%
Off 52-week high−3.45%
Volume1.81M
Avg. volume (3M)1.23M
Market cap139.16B
EPS (TTM)15.54
Forward P/E27.52
P/E ratio (TTM)35.33
Dividend yield—
Beta (5Y)0.28
Shares outstanding253.46M
Short interest1.90% of float
Earnings dateNov 2, 2026
Analyst target576.29
Profit margin30.70%

Against its peers

Compare in full ›
VRTX 095700.KQ KRYS ROIV 1530.HK BBIO
Market cap 139.16B 94.14B 9.21B 27.61B 37.99B 15.17B
P/E (TTM) 35.3 — 42.2 — 4.1 —
Forward P/E 27.5 — 34.0 -27.5 11.2 -225.0
Price/book 6.7 — 6.4 6.5 1.2 -5.9
Dividend yield — — — — 1.69% —
1-year change +27.28% −60.56% +52.61% +78.15% −51.32% +18.15%
Today +3.44% +0.73% +1.90% +6.08% +4.00% +5.21%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All VRTX news ›
The Globe and Mail·Positive

Vertex Pharmaceuticals (VRTX) Receives a Buy from TD Cowen

The Globe and Mail In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $575.00. According to TipRanks, Nadeau is a 4-star analyst with an average return of 6.0% and

From the 4Search news index, newest first.

In the news

156mentions in 30 days
94with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance